|
Match
|
Document |
Document Title |
|
|
6299882 |
UL54.5 of Marek's disease virus (MDV)
The present invention provides methods and reagents for inducing active immunity in animals. In particular, the present invention provides recombinant herpesviruses having foreign DNA that are...
|
|
|
6300134 |
RNA transformation vectors derived from a single-component RNA virus and contain an intervening sequence between the cap and the 5' end
This invention is directed to a plus strand RNA viral vector for transformation of a host organism with a foreign RNA, and expression of said foreign RNA. The foreign RNA is inserted into an...
|
|
|
6300118 |
Plasmids comprising a genetically altered feline immunodeficiency virus genome
The present invention pertains to the prevention or lessening of disease in cats caused by Feline Immunodeficiency Virus (FIV). Prevention or lessening of disease is understood to mean the...
|
|
|
6296853 |
E6 binding proteins
E6-BP polypeptide, nucleic acids encoding E6-BP polypeptides, and uses thereof.
|
|
|
6296852 |
Recombinant avian adenovirus vector
This invention relates to a recombinant vector comprising a recombinant avian adenovirus incorporating, and capable of expression of at least one heterologous nucleotide sequence. The nucleotide...
|
|
|
6297005 |
De novo priming activity of hepatitis C virus replicase
The present invention relates to identification of a novel, de novo priming activity of hepatitis C virus replicase. This activity can be used to screen for anti-HCV replicase compounds, or to...
|
|
|
6294176 |
Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species
The present invention provides a recombinant raccoonpox virus comprising a raccoonpox virus viral genome which contains a foreign DNA sequence inserted into a non-essential region within the...
|
|
|
6291225 |
Process and culture medium for the production of cells infected by a multiple sclerosis-associated virus
Process for in vitro production of a culture or cell line infected by a viral strain associated with multiple sclerosis (MS), according to which a body sample is taken from an individual suffering...
|
|
|
RE37381 |
Vaccine against hepatitis A virus
The present invention provides an attenuated hepatitis A virus useful as a vaccine.
|
|
|
6291227 |
Nucleic acids containing modified human immunodeficiency virus genomes devoid of long terminal repeats encoding non-infectious, replication-deficient, immunogenic retrovirus-like particles
An immunogenic retrovirus-like particle which is non-infectious and non-replicating and which is useful as a candidate vaccine component against retroviral infections, including AIDS and ATLL, is...
|
|
|
6290965 |
DNA encoding human papillomavirus type 6A
The present invention is directed to DNA molecules encoding purified human papillomavirus type 6a and compounds derived therefrom.
|
|
|
6287571 |
Replication-defective adenovirus human type 5 recombinant as a vaccine carrier
A replication defective recombinant adenovirus is provided which contains a complete deletion of its E1 gene and at least a partial deletion of its E3 gene, said virus containing in the site of the...
|
|
|
6284532 |
Purified human papillomavirus
A live, infective stock of a new human papillomavirus, HPV IU, is provided. HPV IU is related to but distinct from HPV MM7 and HPV LVX82. An isolated nucleic acid comprising the genome of HPV IU is...
|
|
|
6284249 |
Fusion polypeptide having the C protein and E1 protein of hepatitis C virus
The invention concerns a pharmaceutical composition for treating or preventing C hepatitis (HCV), induced infections, which in a preferred embodiment, comprises a main active principle, (i) a...
|
|
|
6284253 |
Feline immunodeficiency virus (FIV) nucleotide sequence
This invention relates to a highly cytopathic and infectious clone constructed from the genomic DNA of a cat FIV. The nucleotide sequences of the infectious clone is disclosed. The nucleotide...
|
|
|
6284455 |
Diagnosis of penaeus monodon-type baculovirus by PCR
This invention relates to the methods of detecting Penaeus monodon baculovirus (MBV). Two methods are established: the first one is a polymerase chain reaction (PCR) and the second one is an ELISA....
|
|
|
6281000 |
Method for the preparation of a viral vector by intermolecular homologous recombination
The present invention encompasses methods of preparing a recombinant viral vector, within a procaryotic cell, by intermolecular homologous recombination, methods of preparing an infectious viral...
|
|
|
6280740 |
Formulations of recombinant papillomavirus vaccines
Vaccine formulations comprising recombinant early (E) and late (L) proteins of papillomavirus and oxidized mannan as well as methods of making and using the formulations are provided.
|
|
|
6280734 |
Simian-human HAV having a chimeric 2C protein
The present invention discloses simian-human hepatitis A virus chimeric genomes which encode a hepatitis A virus having a chimeric 2C protein. The invention further discloses the use of these...
|
|
|
6281200 |
Functional characterization of the C-C chemokine-like molecules encoded by molluscum contagiosum virus types 1 and 2
The inventors have cloned and expressed the chemokine-like genes from MCV type 1 and the closely related MCV type 2 in order to determine a potential role for these proteins in the viral life...
|
|
|
6277561 |
Diagnostic assay for detection of HIV
A novel immunodeficiency virus is disclosed which has the designation MVP-5180/91 and which has been deposited with the European Collection of Animal Cell Cultures (ECACC) under No. V 920 92 318....
|
|
|
6277631 |
Recombinant proteins with the immunoreactivity of hepatitis B virus e antigen (HBeAg), a process for the preparation thereof and the use thereof in immunoassays and vaccines
Recombinant yeast expression vectors with the features indicated in the patent claims are described. These recombinant yeast expression vectors can be used for the preparation of HBeAg in yeast...
|
|
|
6277380 |
Measles virus mutant antigen
|
|
|
6277970 |
PRP-like gene
The present invention provides nucleic acids encoding the Doppel ("Dpl") protein, Dpl peptides, and assays utilizing the Dpl nucleic acids and/or peptides. In related aspects the invention features...
|
|
|
6274147 |
Method for generating nonpathogenic infectious pancreatic necrosis virus (IPNV) from synthetic RNA transcripts
A system for the generation of live, nonpathogenic infectious pancreatic necrosis virus (IPNV), a segmented double-stranded (ds)RNA virus of the Birnavirdae family, using synthetic transcripts...
|
|
|
6271444 |
Enhancer elements for increased translation in plant plastids
Provided are methods for increasing the production of protein in a plant cell by transforming plastids of plant cells with a construct comprising a promoter functional in a plant plastid, a...
|
|
|
6268199 |
Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
An infectious clone based on the genome of a wild-type RNA virus is produced by the process of providing a host cell not susceptible to infection by the wild-type RNA virus, providing a recombinant...
|
|
|
6268211 |
Non-infectious HIV transgene
Disclosed herein is a transgenic non-human animal carrying a transgene which expresses non-infectious HIV ribonucleic acid and complementary proteins thereof. Among the expressed proteins, which...
|
|
|
6264958 |
Genes of kaposi's sarcoma associated herpesvirus
A human gamma herpesviris genome known as Kaposi sarcoma associated herpesvirus (KSHV) or human herpesvirus 8 (HHV-8) is present in virtually all AIDS and non-AIDS Kaposi's sarcoma (KS) lesions, as...
|
|
|
6261806 |
Molecular sequence of swine retrovirus and methods of use
This invention relates to newly identified polynucleotides, polypeptides encoded by such polynucleotides, the use of such polynucleotides and polypeptides, as well as the production of such...
|
|
|
6262235 |
Leptospiral outer membranes protein, LipL46
An antigenic preparation is provided containing an outer membrane protein associated with pathogenic strains of Leptospira. The protein has been designated "LipL46" for "lipoprotein from...
|
|
|
6261570 |
Live attenuated virus vaccines for western equine encephalitis virus, eastern equine encephalitis virus, and venezuelan equine encephalitis virus IE and IIIA variants
cDNAs coding for an infectious Western Equine Encephalitis virus (WEE) and infectious Venezuelan Equine Encephalitis virus variant IE (VEE IE) are disclosed in addition to cDNA coding for the...
|
|
|
6258945 |
HIV-1P-17 peptide fragments, compositions containing and methods for producing and using same
Peptide fragments of the p17 gag protein of HIV-1 from Clade C of from about 30 to about 50 amino acids, including the region extending from position 75 to position 129, raise antibodies...
|
|
|
6258363 |
Varicella zoster virus (VZV) immunoreactive protein VP26 and its diagnostic use
Varicella zoster virus (VZV) immunoreactive protein VP26 and its diagnostic use are described. The invention relates to immunoreactive peptides which are homologous with the region of amino acid...
|
|
|
6258530 |
Surface expression libraries of randomized peptides
A composition of matter comprising a plurality of procaryotic cells containing a diverse population of expressible oligonucleotides operationally linked to expression elements, said expressible...
|
|
|
6254873 |
Inactivated dengue virus vaccine
An inactivated dengue virus vaccine to immunize and protect humans against dengue fever is described. The vaccine is based on dengue viruses which have been propagated to high titers in suitable...
|
|
|
6255078 |
Pseudorabies virus protein cross reference to related applications
The present invention provides recombinant DNA molecules comprising a sequence encoding a pseudorabies virus (PRV) glycoprotein selected from the group consisting of gI, gp50, and gp63, host cells...
|
|
|
6255104 |
Recombinant poliovirus vector and method of preparing the same
The invention relates to a recombinant poliovirus vector and method of making the vector. The recombinant poliovirus vector comprises an RNA polymerase promoter operably linked to a poliovirus...
|
|
|
6255560 |
Chimeric genes for transforming plant cells using viral promoters
In one aspect the present invention relates to the use of viral promoters in the expression of chimeric genes in plant cells. In another aspect this invention relates to chimeric genes which are...
|
|
|
6248578 |
Infectious clone for human parainfluenza virus type 3
A system for generating recombinant, human parainfluenza virus, particularly infectious, recombinant, human parainfluenza virus type 3 (HPIV-3) is provided. In one embodiment, the system comprises...
|
|
|
6241990 |
Immunogenic composition containing inactivated swine infertility and respiratory Syndrome virus
The invention includes a vaccine and sera for treatment of Mystery Swine Disease (MSD), a method for producing the vaccine, methods for diagnosis of MSD, a viral agent that will mimic "mystery...
|
|
|
6242259 |
Compositions and methods for packing of alphavirus vectors
Nucleic acid molecule are provided comprising a nucleic acid sequence which encodes, in order, an alphavirus capsid, a signal peptide, and an alphavirus E1 or E2 glycoprotein. Also provided are...
|
|
|
6235881 |
Polypeptides encoded by novel HIV-2 proviruses
Novel HIV-2 proviruses, molecular clones, nucleic acids, polypeptides, viruses and viral components are described. The use of these compositions as components of diagnostic assays, as immunological...
|
|
|
6235523 |
Vectors for DNA immunization against cervical cancer
Vectors for DNA immunization against cervical cancer comprise a nucleic acid molecule encoding at least one non-toxic T-cell epitope of the E6 and/or E7 antigens of a strain of human papilloma...
|
|
|
6231863 |
DNA sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same
Nucleotide sequences obtained from the genome of the capsid gene of FCV strain 2280 wherein the splicing sites have been modified, so as to be deleted or inactivated are provided. The nucleotide...
|
|
|
6231868 |
Method for generating nonpathogenic infections birnavirus from synthetic RNA transcripts
A system for the generation of live, nonpathogenic Birnavirus such as infectious bursal disease virus (IBDV), a segmented double-stranded (ds)RNA virus of the Birnavirdae family, using synthetic...
|
|
|
6228368 |
Papilloma virus capsomere formulations and method of use
Vaccine formulations comprising viral capsomeres are disclosed along with methods for their production. Therapeutic and prophylactic methods of use for the vaccine formulations are also disclosed.
|
|
|
6229005 |
DNA sequences of enterically transmitted non-A/non-B hepatitis viral agent
Viral proteins derived from an enterically transmitted non-A/non-B viral hepatitis agent (HEV) are disclosed. In one embodiment, the protein is immunologically reactive with antibodies present in...
|
|
|
6228608 |
Recombinant FIV glycoprotein 160 and P24 gag protein
Feline immunodeficiency virus antigens from gp160 envelope protein, gp120 envelope protein and p24 gag protein, useful for the diagnosis, treatment, and prevention of FIV. The invention may also be...
|
|
|
6228369 |
Composition of trans-dominant variants of viral proteins for obtaining an anti-viral effect
A composition resulting from a combination of trans-dominant variants of two viral proteins TAT and REV from HIV, and the use thereof as a combination product are disclosed. A vector for expressing...
|